Bluebird bio Inc (NASDAQ:BLUE) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mary Lynne Hedley Other companies: Eli Lilly and Company (Director · Since at least May 15, 2022); Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021); Veeva Systems Inc. (Director · Since at least Aug 16, 2019); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Receptos Inc (Director · Apr 11, 2014 – Aug 27, 2015 · Past); Tesaro Inc (President & COO, Director · Jun 27, 2012 – Jan 22, 2019 · Past); Abraxis BioScience Inc (Executive VP of Ops & CSO · Jul 9, 2009 – Jul 13, 2009 · Past) | Director · Sep 18, 2017 – Jun 20, 2018 · Past |
| Denice Torres Other companies: Seaport Therapeutics, Inc. (Board Member · Since at least Apr 30, 2026); Celldex Therapeutics, Inc. (Chief Executive Officer; The Ignited Company · Since at least Jun 5, 2025); Glaukos Corporation (Director · Since at least Mar 1, 2021); 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Surface Oncology Inc (Director · Jul 6, 2021 – Jun 8, 2022 · Past); Karuna Therapeutics Inc (Director · Dec 22, 2020 – Mar 18, 2024 · Past) | Director · Aug 10, 2020 – Nov 11, 2021 · Past |
| Linda Bain Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Adverum Biotechnologies Inc (Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past) | VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past |
| Mitchell H Finer Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Adverum Biotechnologies Inc (Director · May 11, 2016 – Jul 31, 2019 · Past) | Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past |
| Elisabeth Leiderman Other companies: Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Decibel Therapeutics Inc (Chief Financial Officer · Feb 11, 2021 – Feb 25, 2022 · Past) | Director · Since at least Oct 15, 2021 |
| Jim DeTore Other companies: CG Oncology, Inc. (Chief Financial Officer · Since at least Nov 17, 2025); Kineta Inc. (See Remarks · Aug 4, 2016 – Aug 4, 2016 · Past) | Chief Financial Officer · Nov 10, 2014 – Dec 1, 2014 · Past |
| Michael Cloonan Other companies: Sionna Therapeutics, Inc. (President & CEO, Director · Since at least Feb 6, 2025); Sage Therapeutics Inc (Chief Business Officer · Apr 2, 2018 – Feb 10, 2021 · Past) | Director · Since at least Jun 20, 2024 |
| Nick Leschly Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Synlogic Inc (Director · Jun 10, 2021 – Jun 22, 2023 · Past) | Director · Since at least Oct 2, 2020 |
| Jeffrey T. Walsh Other companies: Tenaya Therapeutics, Inc. (Board Member · Since at least Jul 29, 2021) | Chief Strategy Officer · Mar 11, 2019 – Aug 20, 2019 · Past |
| Joseph Vittiglio Other companies: PepGen Inc. (Chief Business & Legal Officer · Since at least Dec 8, 2025) | Chief Business & Legal Officer · Since at least May 30, 2025 |
| Kory Wentworth Other companies: Entrada Therapeutics, Inc. (Chief Financial Officer · Since at least Oct 28, 2021) | Principal Accounting Officer · Dec 18, 2017 – Aug 3, 2020 · Past |
| Marcela V Maus Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past) | Director · Sep 7, 2021 – Nov 11, 2021 · Past |
| O James Sterling Other companies: Renalytix PLC (Chief Financial Officer · Jul 1, 2023 – Jul 6, 2023 · Past) | Chief Financial Officer · Since at least Jun 10, 2024 |
| Richard Paulson Other companies: Karyopharm Therapeutics Inc. (President and CEO, Director · Since at least Apr 4, 2025) | Director · Since at least May 30, 2025 |
| William R Sellers Other companies: 2Seventy Bio Inc (Director · Oct 18, 2021 – Nov 11, 2021 · Past) | Director · Sep 25, 2019 – Nov 11, 2021 · Past |
| Andrew Obenshain | President and CEO, Director · Since at least Nov 3, 2023 |
| Douglas Melton | Director · Jun 6, 2019 – Jun 18, 2020 · Past |
| Jessica Whitten | Chief Accounting Officer · Nov 4, 2021 – Feb 1, 2022 · Past |
| Katy Burnett | Principal Accounting Officer · Sep 8, 2020 – Feb 16, 2021 · Past |
| Mark Vachon | Director · Since at least Nov 6, 2024 |
| Najoh Tita-Reid | Director · Since at least Jun 22, 2022 |
| Richard A Colvin | Chief Medical Officer · Since at least May 30, 2025 |
| Thomas J Klima | See Remarks · Since at least May 10, 2021 |